{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:27:55Z","timestamp":1789475275622,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS015655"],"award-info":[{"award-number":["P01 NS015655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS070856"],"award-info":[{"award-number":["R01 NS070856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 NS091856"],"award-info":[{"award-number":["P50 NS091856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 RX001631"],"award-info":[{"award-number":["I01 RX001631"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11910-021-01140-z","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T12:31:03Z","timestamp":1632141063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1418-2960","authenticated-orcid":false,"given":"Prabesh","family":"Kanel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Bedard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghmik","family":"Aghourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Albin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas I.","family":"Bohnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"issue":"1","key":"1140_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13670-018-0234-4","volume":"7","author":"NI Bohnen","year":"2018","unstructured":"Bohnen NI, Grothe MJ, Ray NJ, Muller MLTM, Teipel SJ. Recent advances in cholinergic imaging and cognitive decline-revisiting the cholinergic hypothesis of dementia. Curr Geriatr Rep. 2018;7(1):1\u201311. https:\/\/doi.org\/10.1007\/s13670-018-0234-4.","journal-title":"Curr Geriatr Rep"},{"issue":"11","key":"1140_CR2","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1111\/ejn.12515","volume":"39","author":"M Sarter","year":"2014","unstructured":"Sarter M, Lustig C, Howe WM, Gritton H, Berry AS. Deterministic functions of cortical acetylcholine. Eur J Neurosci. 2014;39(11):1912\u201320. https:\/\/doi.org\/10.1111\/ejn.12515.","journal-title":"Eur J Neurosci"},{"key":"1140_CR3","doi-asserted-by":"publisher","unstructured":"Gombkoto P, Gielow M, Varsanyi P, Chavez C, Zaborszky L. Contribution of the basal forebrain to corticocortical network interactions. Brain Struct Funct. 2021. https:\/\/doi.org\/10.1007\/s00429-021-02290-z.","DOI":"10.1007\/s00429-021-02290-z"},{"issue":"3","key":"1140_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2967\/jnumed.113.124792","volume":"55","author":"M Petrou","year":"2014","unstructured":"Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, et al. In vivo imaging of human cholinergic nerve terminals with (-)-5-18F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. J Nucl Med Off Publ Soc Nucl Med. 2014;55(3):396\u2013404. https:\/\/doi.org\/10.2967\/jnumed.113.124792.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"1140_CR5","doi-asserted-by":"publisher","unstructured":"Albin RL, Bohnen NI, Muller M, Dauer WT, Sarter M, Frey KA, et al. Regional vesicular acetylcholine transporter distribution in human brain: a [(18) F]fluoroethoxybenzovesamicol positron emission tomography study. J Compar Neurol. 2018. https:\/\/doi.org\/10.1002\/cne.24541.","DOI":"10.1002\/cne.24541"},{"issue":"18","key":"1140_CR6","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1002\/cne.23415","volume":"521","author":"MM Mesulam","year":"2013","unstructured":"Mesulam MM. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer\u2019s disease. J Comp Neurol. 2013;521(18):4124\u201344. https:\/\/doi.org\/10.1002\/cne.23415.","journal-title":"J Comp Neurol"},{"issue":"1","key":"1140_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/HTR.0b013e31820516cb","volume":"26","author":"DB Arciniegas","year":"2011","unstructured":"Arciniegas DB. Cholinergic dysfunction and cognitive impairment after traumatic brain injury Part 1: the structure and function of cerebral cholinergic systems. J Head Trauma Rehab. 2011;26(1):98\u2013101. https:\/\/doi.org\/10.1097\/HTR.0b013e31820516cb.","journal-title":"J Head trauma Rehab"},{"issue":"8","key":"1140_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1515\/revneuro-2016-0008","volume":"27","author":"C Zhang","year":"2016","unstructured":"Zhang C, Zhou P, Yuan T. The cholinergic system in the cerebellum: from structure to function. Rev Neurosci. 2016;27(8):769\u201376. https:\/\/doi.org\/10.1515\/revneuro-2016-0008.","journal-title":"Rev Neurosci"},{"issue":"5","key":"1140_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/ejn.13949","volume":"49","author":"N Abudukeyoumu","year":"2019","unstructured":"Abudukeyoumu N, Hernandez-Flores T, Garcia-Munoz M, Arbuthnott GW. Cholinergic modulation of striatal microcircuits. Eur J Neurosci. 2019;49(5):604\u201322. https:\/\/doi.org\/10.1111\/ejn.13949.","journal-title":"Eur J Neurosci"},{"key":"1140_CR10","doi-asserted-by":"publisher","unstructured":"Aghourian M, Legault-Denis C, Soucy JP, Rosa-Neto P, Gauthier S, Kostikov A, et al. Quantification of brain cholinergic denervation in Alzheimer\u2019s disease using PET imaging with [(18)F]-FEOBV. Mol Psychiatry. 2017;22(11):1531\u20138. https:\/\/doi.org\/10.1038\/mp.2017.183.\u00a0This study reports the first detailed FEOBV\u00a0PET analysis in patients with AD and reported widespread cortical reductions in VAChT binding.","DOI":"10.1038\/mp.2017.183"},{"issue":"4","key":"1140_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","volume":"129","author":"AK Liu","year":"2015","unstructured":"Liu AK, Chang RC, Pearce RK, Gentleman SM. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease. Acta Neuropathol. 2015;129(4):527\u201340. https:\/\/doi.org\/10.1007\/s00401-015-1392-5.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1140_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.celrep.2018.06.001","volume":"24","author":"TW Schmitz","year":"2018","unstructured":"Schmitz TW, Mur M, Aghourian M, Bedard MA, Spreng RN. Alzheimer\u2019s Disease Neuroimaging I Longitudinal Alzheimer\u2019s degeneration reflects the spatial topography of cholinergic basal forebrain projections. Cell reports. 2018;24(1):38\u201346. https:\/\/doi.org\/10.1016\/j.celrep.2018.06.001.","journal-title":"Cell reports."},{"issue":"1","key":"1140_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cne.903300103","volume":"330","author":"S Lehericy","year":"1993","unstructured":"Lehericy S, Hirsch EC, Cervera-Pierot P, Hersh LB, Bakchine S, Piette F, et al. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer\u2019s disease. J Comp Neurol. 1993;330(1):15\u201331. https:\/\/doi.org\/10.1002\/cne.903300103.","journal-title":"J Comp Neurol"},{"key":"1140_CR14","doi-asserted-by":"publisher","unstructured":"Mazere J, Lamare F, Allard M, Fernandez P, Mayo W. 123I-Iodobenzovesamicol SPECT imaging of cholinergic systems in dementia with Lewy bodies. Journal of nuclear medicine\u202f: official publication, Society of Nuclear Medicine. 2017;58(1):123\u20138. https:\/\/doi.org\/10.2967\/jnumed.116.176180.\u00a0First VAChT SPECT\u00a0study in DLB.","DOI":"10.2967\/jnumed.116.176180"},{"key":"1140_CR15","doi-asserted-by":"publisher","unstructured":"Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Muller M, Bohnen NI. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [(18)F]-FEOBV. Mol Psychiatry. 2019;24(3):322\u20137. https:\/\/doi.org\/10.1038\/s41380-018-0130-5.\u00a0This study reported VAChT binding\u00a0losses in patients with DLB in the whole neocortex, hippocampus, amygdala, thalamus, basal ganglia,\u00a0vermis, and dorsal pontomesenchephalic region.","DOI":"10.1038\/s41380-018-0130-5"},{"key":"1140_CR16","doi-asserted-by":"publisher","unstructured":"Kanel P, M\u00fcller MLTM, van der Zee S, Sanchez-Catasus CA, Koeppe RA, Frey KA, et al. Topography of cholinergic changes in dementia with Lewy bodies and key neural network hubs. J Neuropsychiatry Clin Neurosci. 2020;32(4):370\u20135. https:\/\/doi.org\/10.1176\/appi.neuropsych.19070165. The authors used a different imaging analysis method (whole brain voxel-based analyses) and found a distinct topographic pattern of VAChT binding losses in patients with DLB. Regionally more prominent losses were seen in the bilateral opercula, anterior-to-mid cingulate cortices, bilateral insula, bilateral geniculate nuclei, pulvinar, right proximal optic radiation, bilateral anterior and superior thalami, and posterior hippocampal fimbria and fornix.","DOI":"10.1176\/appi.neuropsych.19070165"},{"issue":"7","key":"1140_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1162\/0899766053723023","volume":"17","author":"C Habeck","year":"2005","unstructured":"Habeck C, Krakauer JW, Ghez C, Sackeim HA, Eidelberg D, Stern Y, et al. A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput. 2005;17(7):1602\u201345. https:\/\/doi.org\/10.1162\/0899766053723023.","journal-title":"Neural Comput"},{"key":"1140_CR18","doi-asserted-by":"publisher","unstructured":"Schumacher J, Gunter JL, Przybelski SA, Jones DT, Graff-Radford J, Savica R, et al. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks. Brain. 2021. https:\/\/doi.org\/10.1093\/brain\/awab218.","DOI":"10.1093\/brain\/awab218"},{"issue":"12","key":"1140_CR19","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/s41593-017-0020-1","volume":"20","author":"MM Halassa","year":"2017","unstructured":"Halassa MM, Kastner S. Thalamic functions in distributed cognitive control. Nat Neurosci. 2017;20(12):1669\u201379. https:\/\/doi.org\/10.1038\/s41593-017-0020-1.","journal-title":"Nat Neurosci"},{"key":"1140_CR20","doi-asserted-by":"publisher","unstructured":"Mihai PG, Moerel M, de Martino F, Trampel R, Kiebel S, von Kriegstein K. Modulation of tonotopic ventral medial geniculate body is behaviorally relevant for speech recognition. Elife. 2019;8. https:\/\/doi.org\/10.7554\/eLife.44837.","DOI":"10.7554\/eLife.44837"},{"issue":"4\u20135","key":"1140_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/(sici)1097-0029(19990815\/01)46:4\/5<281::Aid-jemt5>3.0.Co;2-n","volume":"46","author":"P Phansuwan-Pujito","year":"1999","unstructured":"Phansuwan-Pujito P, M\u00f8ller M, Govitrapong P. Cholinergic innervation and function in the mammalian pineal gland. Microsc Res Tech. 1999;46(4\u20135):281\u201395. https:\/\/doi.org\/10.1002\/(sici)1097-0029(19990815\/01)46:4\/5%3c281::Aid-jemt5%3e3.0.Co;2-n.","journal-title":"Microsc Res Tech"},{"key":"1140_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cne.903250107","volume":"325","author":"S Heckers","year":"1992","unstructured":"Heckers S, Geula C, Mesulam M. Cholinergic innervation of the human thalamus: dual origin and differential nuclear distribution. J Comp Neurol. 1992;325:68\u201382.","journal-title":"J Comp Neurol"},{"issue":"2","key":"1140_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mds.27252","volume":"33","author":"SH Lee","year":"2018","unstructured":"Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS, et al. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases. Movement Disorders Off J Movement Disorder Soc. 2018;33(2):262\u201372. https:\/\/doi.org\/10.1002\/mds.27252.","journal-title":"Movement Disorders Off J Movement Disorder Soc"},{"issue":"6","key":"1140_CR24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/ana.24937","volume":"81","author":"K Seidel","year":"2017","unstructured":"Seidel K, Bouzrou M, Heidemann N, Kr\u00fcger R, Sch\u00f6ls L, den Dunnen WFA, et al. Involvement of the cerebellum in Parkinson disease and dementia with Lewy bodies. Ann Neurol. 2017;81(6):898\u2013903. https:\/\/doi.org\/10.1002\/ana.24937.","journal-title":"Ann Neurol"},{"issue":"12","key":"1140_CR25","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","volume":"60","author":"NI Bohnen","year":"2003","unstructured":"Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol. 2003;60(12):1745\u20138. https:\/\/doi.org\/10.1001\/archneur.60.12.1745.","journal-title":"Arch Neurol"},{"issue":"3","key":"1140_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ana.410400309","volume":"40","author":"DE Kuhl","year":"1996","unstructured":"Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer\u2019s disease, and Parkinson\u2019s disease. Ann Neurol. 1996;40(3):399\u2013410. https:\/\/doi.org\/10.1002\/ana.410400309.","journal-title":"Ann Neurol"},{"issue":"4","key":"1140_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3233\/jad-170749","volume":"62","author":"S Hirano","year":"2018","unstructured":"Hirano S, Shinotoh H, Shimada H, Ota T, Sato K, Tanaka N, et al. Voxel-based acetylcholinesterase PET study in early and late onset Alzheimer\u2019s disease. J Alzheimers Dis. 2018;62(4):1539\u201348. https:\/\/doi.org\/10.3233\/jad-170749.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1140_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","volume":"77","author":"FS Hanna Al-Shaikh","year":"2020","unstructured":"Hanna Al-Shaikh FS, Duara R, Crook JE, Lesser ER, Schaeverbeke J, Hinkle KM, et al. Selective vulnerability of the nucleus basalis of Meynert among neuropathologic subtypes of Alzheimer disease. JAMA Neurol. 2020;77(2):225\u201333. https:\/\/doi.org\/10.1001\/jamaneurol.2019.3606.","journal-title":"JAMA Neurol"},{"issue":"11","key":"1140_CR29","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","volume":"65","author":"R Hilker","year":"2005","unstructured":"Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology. 2005;65(11):1716\u201322. https:\/\/doi.org\/10.1212\/01.wnl.0000191154.78131.f6.","journal-title":"Neurology"},{"issue":"6","key":"1140_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/mds.27698","volume":"34","author":"S van der Zee","year":"2019","unstructured":"van der Zee S, V\u00e1llez Garc\u00eda D, Elsinga PH, Willemsen ATM, Boersma HH, Gerritsen MJJ, et al. [18F]Fluoroethoxybenzovesamicol in Parkinson\u2019s disease patients: quantification of a novel cholinergic positron emission tomography tracer. Movement Disorders Off J Movement Disorder Soc. 2019;34(6):924\u20136. https:\/\/doi.org\/10.1002\/mds.27698.","journal-title":"Movement Disorders Off J Movement Disorder Soc"},{"issue":"3","key":"1140_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/mds.28360","volume":"36","author":"S van der Zee","year":"2021","unstructured":"van der Zee S, Muller M, Kanel P, van Laar T, Bohnen NI. Cholinergic denervation patterns across cognitive domains in Parkinson\u2019s disease. Movement Disorders Off J Movement Disorder Soc. 2021;36(3):642\u201350. https:\/\/doi.org\/10.1002\/mds.28360.","journal-title":"Movement Disorders Off J Movement Disorder Soc"},{"issue":"10","key":"1140_CR32","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","volume":"21","author":"H Fu","year":"2018","unstructured":"Fu H, Hardy J, Duff KE. Selective vulnerability in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1350\u20138. https:\/\/doi.org\/10.1038\/s41593-018-0221-2.","journal-title":"Nat Neurosci"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01140-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-021-01140-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01140-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T04:41:42Z","timestamp":1635914502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-021-01140-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1007\/s11910-021-01140-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"13 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"52"}}